Prospective DPYD genotyping to reduce the risk of fluoropyrimidine-induced severe toxicity: Ready for prime time

Author(s):
Lunenburg, C.A.T.C. (0000-0003-0173-9803); Henricks, L.M.; Guchelaar, H.J. (0000-0002-7085-1383); Swen, J.J.; Deenen, M.J.; Schellens, J.H.M.; Gelderblom, H.
Published
2016
Publication type
Article / Letter to editor
Dihydropyrimidine dehydrogenaseDPYDFluoropyrimidinesCapecitabine5-FluorouracilPharmacogenomicsIndividualised medicine
Date issued
2016-02-28
Language
English
Is part of
European Journal of Cancer (2016), Vol. 54, p. 40-48
hdl
1887/100197
doi
10.1016/j.ejca.2015.11.008